{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:29:14Z","timestamp":1795080554139,"version":"4.10.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070220"],"award-info":[{"award-number":["82070220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170789"],"award-info":[{"award-number":["32170789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100563"],"award-info":[{"award-number":["32100563"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270209"],"award-info":[{"award-number":["82270209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Multiple myeloma is a hematologic malignancy characterized by complex interactions within the tumor microenvironment, where mesenchymal stem cells (MSCs) contribute significantly to disease progression, immune suppression, and drug resistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study investigated the heterogeneity of MSCs in multiple myeloma using single-cell RNA sequencing (10X) and bulk transcriptomic data. Further analysis was performed by Seurat, SCENIC, CellChat. GSE4581 and GSE136337 were used as training set and validation set to construct a newly described prognostic model through COX and LASSO.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>By analyzing bone marrow samples from healthy donors and multiple myeloma patients at different Revised International Staging System (R-ISS) stages, this study identified distinct MSC subpopulations, including osteogenic, angiogenic, immune regulatory, and multipotent clusters, each of which plays unique roles in the tumor microenvironment. Interestingly, we found a unique subclone with upregulated expression of high mobility group proteins, these MSC exert a strong regulatory effect, which was defined as \u201cHMGhMSC\u201d.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings reveal that the proportion of osteogenic MSCs, which are crucial for bone health, decreases as the disease progresses, which is correlated with the bone lysis commonly observed in advanced multiple myeloma. Additionally, immune regulatory MSCs contribute to the formation of an immunosuppressive microenvironment, promoting tumor immune evasion. A prognostic model based on HMGhMSC subpopulations was developed, which demonstrated that these cells have significant potential as therapeutic targets for improving the prognosis and developing treatments for bone disease in multiple myeloma patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12967-025-06637-6","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T17:31:15Z","timestamp":1750095075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrative analysis of bulk and single-cell gene expression profiles to identify bone marrow mesenchymal cell heterogeneity and prognostic significance in multiple myeloma"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-7388","authenticated-orcid":false,"given":"Fei-Er","family":"Ju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Na","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Lan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Xia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Ding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"6637_CR1","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1038\/s41467-021-22804-x","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, et al. Co-evolution of tumor and immune cells during progression of multiple myeloma. Nat Commun. 2021;12:2559. https:\/\/doi.org\/10.1038\/s41467-021-22804-x.","journal-title":"Nat Commun"},{"key":"6637_CR2","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.immuni.2023.11.008","volume":"56","author":"O Dufva","year":"2023","unstructured":"Dufva O, et al. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers. Immunity. 2023;56:2816\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2023.11.008.","journal-title":"Immunity"},{"key":"6637_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41408-018-0160-x","volume":"9","author":"JS Jang","year":"2019","unstructured":"Jang JS, et al. Molecular signatures of multiple myeloma progression through single cell RNA-Seq. Blood Cancer J. 2019;9:2. https:\/\/doi.org\/10.1038\/s41408-018-0160-x.","journal-title":"Blood Cancer J"},{"key":"6637_CR4","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41591-018-0269-2","volume":"24","author":"G Ledergor","year":"2018","unstructured":"Ledergor G, et al. Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma. Nat Med. 2018;24:1867\u201376. https:\/\/doi.org\/10.1038\/s41591-018-0269-2.","journal-title":"Nat Med"},{"key":"6637_CR5","doi-asserted-by":"publisher","first-page":"363ra147","DOI":"10.1126\/scitranslmed.aac7037","volume":"8","author":"JG Lohr","year":"2016","unstructured":"Lohr JG, et al. Genetic interrogation of circulating multiple myeloma cells at single-cell resolution. Sci Transl Med. 2016;8:363ra147. https:\/\/doi.org\/10.1126\/scitranslmed.aac7037.","journal-title":"Sci Transl Med"},{"key":"6637_CR6","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/leu.2014.13","volume":"28","author":"L Melchor","year":"2014","unstructured":"Melchor L, et al. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia. 2014;28:1705\u201315. https:\/\/doi.org\/10.1038\/leu.2014.13.","journal-title":"Leukemia"},{"key":"6637_CR7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1182\/blood.2023019758","volume":"142","author":"AM Poos","year":"2023","unstructured":"Poos AM, et al. Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis. Blood. 2023;142:1633\u201346. https:\/\/doi.org\/10.1182\/blood.2023019758.","journal-title":"Blood"},{"key":"6637_CR8","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-22-1769","volume":"83","author":"L Yao","year":"2023","unstructured":"Yao L, et al. Single-cell discovery and multiomic characterization of therapeutic targets in multiple myeloma. Cancer Res. 2023;83:1214\u201333. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1769.","journal-title":"Cancer Res"},{"key":"6637_CR9","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1038\/s41467-021-26951-z","volume":"12","author":"SM Tirier","year":"2021","unstructured":"Tirier SM, et al. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nat Commun. 2021;12:6960. https:\/\/doi.org\/10.1038\/s41467-021-26951-z.","journal-title":"Nat Commun"},{"key":"6637_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ccell.2023.05.007","volume":"41","author":"M Dang","year":"2023","unstructured":"Dang M, et al. Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease. Cancer Cell. 2023;41:1032\u201347. https:\/\/doi.org\/10.1016\/j.ccell.2023.05.007.","journal-title":"Cancer Cell"},{"key":"6637_CR11","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1172\/JCI88169","volume":"128","author":"Y Kawano","year":"2018","unstructured":"Kawano Y, et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest. 2018;128:2487\u201399. https:\/\/doi.org\/10.1172\/JCI88169.","journal-title":"J Clin Invest"},{"key":"6637_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ccell.2018.02.007","volume":"33","author":"K Nakamura","year":"2018","unstructured":"Nakamura K, et al. Dysregulated IL-18 is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment. Cancer Cell. 2018;33:634\u201348. https:\/\/doi.org\/10.1016\/j.ccell.2018.02.007.","journal-title":"Cancer Cell"},{"key":"6637_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/path.4860","volume":"241","author":"N De Beule","year":"2017","unstructured":"De Beule N, et al. Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation. J Pathol. 2017;241:534\u201346. https:\/\/doi.org\/10.1002\/path.4860.","journal-title":"J Pathol"},{"key":"6637_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","volume":"1","author":"O Zavidij","year":"2020","unstructured":"Zavidij O, et al. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer. 2020;1:493\u2013506. https:\/\/doi.org\/10.1038\/s43018-020-0053-3.","journal-title":"Nat Cancer"},{"key":"6637_CR15","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood-2011-04-347484","volume":"120","author":"I Bruns","year":"2012","unstructured":"Bruns I, et al. Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells. Blood. 2012;120:2620\u201330. https:\/\/doi.org\/10.1182\/blood-2011-04-347484.","journal-title":"Blood"},{"key":"6637_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41419-019-1959-5","volume":"10","author":"C Giallongo","year":"2019","unstructured":"Giallongo C, et al. TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma. Cell Death Dis. 2019;10:704. https:\/\/doi.org\/10.1038\/s41419-019-1959-5.","journal-title":"Cell Death Dis"},{"key":"6637_CR17","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1182\/bloodadvances.2023011632","volume":"8","author":"L Bogun","year":"2024","unstructured":"Bogun L, et al. Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. Blood Adv. 2024;8:2575\u201388. https:\/\/doi.org\/10.1182\/bloodadvances.2023011632.","journal-title":"Blood Adv"},{"key":"6637_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13059-019-1662-y","volume":"20","author":"ATL Lun","year":"2019","unstructured":"Lun ATL, et al. EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol. 2019;20:63. https:\/\/doi.org\/10.1186\/s13059-019-1662-y.","journal-title":"Genome Biol"},{"key":"6637_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320. https:\/\/doi.org\/10.1038\/nbt.4096.","journal-title":"Nat Biotechnol"},{"key":"6637_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8:329\u201337. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003.","journal-title":"Cell Syst"},{"key":"6637_CR21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"key":"6637_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/bioinformatics\/btu674","volume":"31","author":"NC Chung","year":"2015","unstructured":"Chung NC, Storey JD. Statistical significance of variables driving systematic variation in high-dimensional data. Bioinformatics. 2015;31:545\u201354. https:\/\/doi.org\/10.1093\/bioinformatics\/btu674.","journal-title":"Bioinformatics"},{"key":"6637_CR23","unstructured":"Noack A, Rotta R. in International symposium on experimental algorithms. 257\u2013268 (Springer)."},{"key":"6637_CR24","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14:1083\u20136. https:\/\/doi.org\/10.1038\/nmeth.4463.","journal-title":"Nat Methods"},{"key":"6637_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012776","author":"VA Huynh-Thu","year":"2010","unstructured":"Huynh-Thu VA, Irrthum A, Wehenkel L, Geurts P. Inferring regulatory networks from expression data using tree-based methods. PLoS ONE. 2010. https:\/\/doi.org\/10.1371\/journal.pone.0012776.","journal-title":"PLoS ONE"},{"key":"6637_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382. https:\/\/doi.org\/10.1038\/s41587-019-0114-2.","journal-title":"Nat Biotechnol"},{"key":"6637_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005026","author":"R Raja","year":"2022","unstructured":"Raja R, et al. PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2022-005026.","journal-title":"J Immunother Cancer"},{"key":"6637_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s43587-023-00564-1","volume":"4","author":"X Hao","year":"2024","unstructured":"Hao X, et al. TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammation. Nat Aging. 2024;4:185\u201397. https:\/\/doi.org\/10.1038\/s43587-023-00564-1.","journal-title":"Nat Aging"},{"key":"6637_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009039","author":"MK Moutafi","year":"2024","unstructured":"Moutafi MK, et al. High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC). J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2024-009039.","journal-title":"J Immunother Cancer"},{"key":"6637_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1158\/2326-6066.CIR-21-0061","volume":"10","author":"W Celus","year":"2022","unstructured":"Celus W, et al. Plexin-A4 mediates cytotoxic T-cell trafficking and exclusion in cancer. Cancer Immunol Res. 2022;10:126\u201341. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0061.","journal-title":"Cancer Immunol Res"},{"key":"6637_CR31","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1172\/JCI123360","volume":"128","author":"JD Klement","year":"2018","unstructured":"Klement JD, et al. An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549\u201360. https:\/\/doi.org\/10.1172\/JCI123360.","journal-title":"J Clin Invest"},{"key":"6637_CR32","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/cas.12917","volume":"107","author":"C Ma","year":"2016","unstructured":"Ma C, et al. Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma. Cancer Sci. 2016;107:700\u20137. https:\/\/doi.org\/10.1111\/cas.12917.","journal-title":"Cancer Sci"},{"key":"6637_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.775194","volume":"8","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, et al. CD44-mediated poor prognosis in glioma is associated with M2-polarization of tumor-associated macrophages and immunosuppression. Front Surg. 2021;8: 775194. https:\/\/doi.org\/10.3389\/fsurg.2021.775194.","journal-title":"Front Surg"},{"key":"6637_CR34","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1080\/21691401.2017.1408116","volume":"46","author":"R Farajzadeh","year":"2018","unstructured":"Farajzadeh R, et al. Macrophage repolarization using CD44-targeting hyaluronic acid-polylactide nanoparticles containing curcumin. Artif Cells Nanomed Biotechnol. 2018;46:2013\u201321. https:\/\/doi.org\/10.1080\/21691401.2017.1408116.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"6637_CR35","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1158\/0008-5472.CAN-13-0087","volume":"73","author":"EL Spaeth","year":"2013","unstructured":"Spaeth EL, et al. Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res. 2013;73:5347\u201359. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0087.","journal-title":"Cancer Res"},{"key":"6637_CR36","doi-asserted-by":"publisher","first-page":"1121130","DOI":"10.3389\/fonc.2023.1121130","volume":"13","author":"X Zhai","year":"2023","unstructured":"Zhai X, et al. Gas6\/AXL pathway: immunological landscape and therapeutic potential. Front Oncol. 2023;13:1121130. https:\/\/doi.org\/10.3389\/fonc.2023.1121130.","journal-title":"Front Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06637-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06637-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06637-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T06:02:25Z","timestamp":1750140145000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06637-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6637"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06637-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflicts of interest were disclosed by all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"659"}}